President Trump on Tuesday night threatened to start levying 100% tariffs on imported branded drugs made by companies that haven't committed to building new U.S. facilities by Oct. 1.
Why it matters: The move raises the stakes for drug manufacturers already under pressure from the administration to lower U.S. prices.